Company: CMND
Filing Date: 2025-11-26
Form Type: F-1
Source: 0001213900-25-115501
Chunk: 10

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-26
Form: F-1
Chunk 10
---
 food, shopping, gambling, sex, television, and technology, many of which increased in prevalence during the recent pandemic,
can all be destructive when their use cannot be managed and all can potentially be treated by MEAI.

Corporate Information

We were incorporated under the name Cyntar Ventures
Inc. on July 18, 2017, pursuant to the provisions of the Business Corporations Act(British Columbia). On March 24, 2021,
we changed our name to Clearmind Medicine Inc.

Our principal executive offices are located at
101 – 1220 W. 6th Ave, Vancouver, BC V6H1A5. Our telephone number is 973.536.1016. Our website address is https://www.clearmindmedicine.com/.
The information contained on our website and available through our website is not incorporated by reference into and should not be considered
a part of this prospectus, and the reference to our website in this prospectus is an inactive textual reference only.

Recent Developments

Nasdaq Minimum Stockholders’ Equity Requirement

On November 3, 2025, we received
a written notification, or the Notification Letter, from the Listing Qualifications Department of Nasdaq Stock Market LLC, or Nasdaq,
notifying us that we are no longer in compliance with Nasdaq Listing Rule 5550(b)(1), or the Minimum Stockholders’ Equity Rule.

The Minimum Stockholders’
Equity requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders' equity for continued
listing. However, based on our Form 6-K filed on September 11, 2025, where the Company filed its unaudited condensed interim consolidated
financial statements for the three and nine months ended July 31, 2025, filed on September 11, 2025, we reported a stockholders’
equity of $1,065,668, and we do not meet the alternatives of market value of listed securities or net income from continuing operations.
We are thus non-compliant with the Minimum Stockholders’ Equity Rule.

The Notification Letter has
no immediate effect on our listing on The Nasdaq Capital Market at this time, nor are our business operations affected by receipt of the
Notification Letter. In accordance with the Nasdaq Listing Rules, the Company has 45 calendar days, or until December 18, 2025, to submit
a plan to regain compliance. If the plan is accepted,